]>
IRCT20120704010181N12 IRCT 2018-05-12 Ahvaz University of Medical Sciences The effect of dill powder on the treatment of type 2 diabetic patients Assessment of the effect of dill powder on gastrointestinal symptoms, glycemic control, lipid profile, serum levels of oxidant and Inflammatory markers in type 2 diabetic patients 2018-01-20 anticipated 48 Complete https://irct.ir/trial/29037 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple (assigning a person to a particular group completely randomly) using a random number table, Blinding description: In this double blind study neither the patients nor researcher the treatment know which capsules are being received. In fact, a third person who knows the contents of the capsules distributes supplements among the participants. The shape, size and color of the capsules are similar in both groups, while their content is different. 3 diabetes. Intervention 1: Dill powder, 1 gram , three capsule per day for 8 weeks. Intervention 2: placebo, 1 gram , three capsule per day for 8 weeks. No - There is not a plan to make this available Justification or reason for not sharing IPD is it is not the objective of this study.
public Golnaz Amoohi Foroushani
Golestan Highway
Ahvaz Iran (Islamic Republic of) 61357-15794 +98 61 3221 1503 Golnazamoochi@gmail.com Ahvaz University of Medical Sciences scientific Fatemeh Haidari
Golestan Highway
Ahvaz Iran (Islamic Republic of) 61357-15794 +98 61 3373 8317 haidari-f@ajums.ac.ir Ahvaz University of Medical Sciences Iran (Islamic Republic of) Patients with type 2 diabetic Body mass index between 25-35 Age between 30-60 years Desire to collaborate on the research project 30 years 60 years Both Having other endocrine diseases, cardiovascular, liver, kidney, thyroid Taking steroids or hormone medications, consumption vitamin , herbal, mineral or, antioxidants supplements in the last three months Having physical activity Weight loss diet pregnancy lactation ,E10-E14 Diabetes mellitus Treatment - Other Treatment - Other Dill powder, 1 gram , three capsule per day for 8 weeks placebo, 1 gram , three capsule per day for 8 weeks Fasting Glucose. Timepoint: baseline, 8 weeks after intervention period. Method of measurement: Fasting serum Glucose concentration in mg/dl by kit. Serum levels of insulin. Timepoint: baseline, 8 weeks after intervention period. Method of measurement: Fasting serum Insulin concentration in µU/ml by kit. Serum Fructosamine. Timepoint: baseline, 8 weeks after intervention period. Method of measurement: Fasting serum Fructosamine concentration in µmol/L by kit. Serum cholestrol. Timepoint: baseline, 8 weeks after intervention period. Method of measurement: Fasting Serum cholestrol concentration in mg/dl by kit. LDL Cholestrol. Timepoint: baseline, 8 weeks after intervention period. Method of measurement: Fasting Serum HDL Cholestrol concentration in mg/dl, calculating by Friedewald formula. HDL Cholestrol. Timepoint: baseline, 8 weeks after intervention period. Method of measurement: Fasting Serum HDL Cholestrol concentration in mg/dl by kit. Serum Teriglycerid. Timepoint: baseline, 8 weeks after intervention period. Method of measurement: Fasting serum Teriglycerid concentration in mg/dl by kit. Hs- CRP. Timepoint: baseline, 8 weeks after intervention period. Method of measurement: serum hs- CRP concentration in mg/L by kit. Serum malondialdehyde. Timepoint: baseline, 8 weeks after intervention period. Method of measurement: Fasting serum malondialdehyde concentration in µmol/ml by kit. Total Antioxidant Capacity. Timepoint: baseline, 8 weeks after intervention period. Method of measurement: Fasting serum Total Antioxidant Capacity in U/ml by kit. Gastrointestinal symptoms. Timepoint: baseline, 8 weeks after intervention period. Method of measurement: Using the questionnaire by percentage. Body Mass Index. Timepoint: baseline, 8 weeks after intervention period. Method of measurement: body weight / hight square (kg/m2). Ahvaz University of Medical Sciences Approved 2017-11-20 Ethics Committee of Ahwaz University of Medical Sciences Golestan Highway ahvaz Khouzestan Iran (Islamic Republic of)